MustGrow: CEO Letter to Shareholders 2025
Saskatoon, Saskatchewan--(Newsfile Corp. - December 18, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to issue a letter to shareholders from Corey Giasson, MustGrow's President and CEO. Dear MustGrow shareholders and stakeholders, I hope everyone is well and ready to enjoy a peaceful and festive holiday season with family and friends. I am writing this letter to share our excitement in what was a truly transformational year...
2025-12-18 7:00 AM EST
MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)
Saskatoon, Saskatchewan--(Newsfile Corp. - December 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce outstanding perf
2025-12-10 7:00 AM EST
MustGrow Announces Record Q3-2025 Results
Saskatoon, Saskatchewan--(Newsfile Corp. - November 25, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce its operating and financial results for the three months ended
2025-11-25 4:00 PM EST
MustGrow Announces Grant of RSUs and DSUs
Saskatoon, Saskatchewan--(Newsfile Corp. - September 26, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") today announced that the board of directors of the Company authorized and approved the grant of a total of 1,660,315 deferred share units ("DSUs") and restricted share units ("RSUs") to certain directors, officers, and consultants of the Company, effective September 25, 2025. This grants of DSUs and RSUs are made pursuant to the...
2025-09-26 7:00 AM EDT
MustGrow Secures $2 Million Line of Credit with CIBC; Guaranteed by EDC
Saskatoon, Saskatchewan--(Newsfile Corp. - September 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce it has secured a $2.0 million line of credit with Canadian Imperial Bank of Commerce, guaranteed by Canada's Export Development Canada ("EDC") (the "LOC"). Access to funds will allow MustGrow to produce its organic mustard-derived biofertility product TerraSanteTM to meet growing demand from U.S. commercial...
2025-09-10 7:00 AM EDT
MustGrow Closes Non-Brokered LIFE Offering of Approximately $2.1 Million, Repricing of Warrants, and Shares for Debt Settlement
Saskatoon, Saskatchewan--(Newsfile Corp. - August 29, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce: (i) the closing of its previously annoucned non-brokered private placement of 3,059,731 units of the Company (each, a "Unit") at a price of $0.70 per Unit for gross proceeds of approximately $2,141,812 (the "LIFE Offering"); (ii) the repricing of outstanding share purchase warrants issued pursuant to its January...
2025-08-29 7:00 AM EDT
MustGrow Announces Record Q2-2025 Results: $2.8 Million Revenue and 20.9% Gross Profit Margin for the Quarter
Saskatoon, Saskatchewan--(Newsfile Corp. - August 27, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce its operating and financial results for the three months ended June 30, 2025. For complete details, please refer to the Q2-2025 Condensed Interim F
2025-08-27 7:00 PM EDT
MustGrow annonce un placement sans intermédiaire sous le régime de la dispense pour financement de l'émetteur coté d'un montant maximal de 3 millions de dollars, une proposition de révision du prix des bons de souscription, et une offre d'actions aux porteurs de débentures aux fins du règlement de dettes
Saskatoon, Saskatchewan--(Newsfile Corp. - 12 août 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (la « Société » ou « MustGrow »), a le plaisir d'annoncer ce qui suit : i) un placement privé sans intermédiaire d'un maximum de 4 285 715 unités de la Société (chacune, une « unité ») au prix de 0,70 $ par unité pour un produit brut pouvant atteindre 3 000 000 $ (le « placement sous le régime de la dispense »); ii) la proposition de révision du prix des bons de...
2025-08-12 7:46 PM EDT
MustGrow Announces Non-Brokered LIFE Offering of up to $3 Million, Proposed Repricing of Warrants, and Shares for Debt Settlement Offer to Debentureholders
Saskatoon, Saskatchewan--(Newsfile Corp. - July 30, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the following: (i) a non-brokered private placement of up to 4,285,715 units of the Company (each, a "Unit") at a price of $0.70 per Unit for gross proceeds of up to $3,000,000 (the "LIFE Offering"); (ii) the proposed repricing of outstanding share purchase warrants issued pursuant to its January 16, 2025 private...
2025-07-30 7:00 AM EDT
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
Saskatoon, Saskatchewan--(Newsfile Corp. - June 26, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), is pleased to announce the results of its 2025 annual meeting of shareholders (the "Meeting") held on June 26, 2025. At the Meeting, all director nominees listed in the Company's management information circular dated May 28, 2025 were elected by shareholders as directors of the Company on a vote held by ballot. The results of the ballot...
2025-06-26 6:15 PM EDT
MustGrow and Phospholutions Sign Canadian Distribution Agreement for Phosphorous Efficiency Product - RhizoSorb(R)
Saskatoon, Saskatchewan--(Newsfile Corp. - June 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce the addition of Phospholutions Inc.'s ("Phospholutions") RhizoSorb® phosphorous efficiency product. MustGrow and
2025-06-10 7:00 AM EDT
MustGrow Announces Record Q1-2025 Results: $3.8 Million Revenue, 14.3% Gross Profit Margin, $4.4 Million in Cash and Inventory
Saskatoon, Saskatchewan--(Newsfile Corp. - May 27, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce its operating and financial results for the three months ended March 31, 2025. For complete details, please refer to the Q1-2025 Condensed Inte
2025-05-27 5:00 PM EDT
MustGrow Adds New Biostimulants and Inoculants to Canadian Product Portfolio
Saskatoon, Saskatchewan--(Newsfile Corp. - April 1, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce the addition of three cutting-edge biological solutions to MustGrow's existing Canadian product lines through its recently acquired Canadian sales and distribution division, NexusBioAg. Product website linked here: NexusBioAg. MustGrow now...
2025-04-01 7:00 AM EDT
MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line
Saskatoon, Saskatchewan--(Newsfile Corp. - February 11, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce a five-year exclusive distribution agreement was signed on February 4, 2025 (the "Agreement") with Adjuvants Plus Inc. ("Adjuvants"), a Canadian regenerative agriculture company. Under the Agreement, MustGrow will distribute Adjuvants'...
2025-02-11 7:00 AM EST
MustGrow Announces Closing of Private Placement of Units for $2,585,000
Saskatoon, Saskatchewan--(Newsfile Corp. - January 16, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the closing of the previously announced non-brokered private placement of units (each, a "Unit") at a price per Unit of $1,000 for aggregate gross proceeds to the Company of $2,585,000 (the "Private Placement") on January 16, 2025 (the "Closing Date"). Each Unit is comprised of: (i) $1,000 principal amount of...
2025-01-16 5:51 PM EST
MustGrow Biologics Completes Acquisition of NexusBioAg
Saskatoon, Saskatchewan--(Newsfile Corp. - January 2, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the execution and closing of an Asset Purchase Agreement (the "APA") dated December 31, 2024 with Univar Solutions Canada Ltd. ("Univar Solutions") for the acquisition of certain assets that represent NexusBioAg ("NexusBioAg"). MustGrow's acquisition of NexusBioAg positions the Company as a fully integrated provider...
2025-01-02 7:00 AM EST
MustGrow Biologics Announces Proposed Private Placement of Units for Approximately $2 Million
Saskatoon, Saskatchewan--(Newsfile Corp. - December 11, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce a proposed non-brokered private placement of approximately 2,000 units (each, a "Unit") at a price per Unit of $1,000 for aggregate gross proceeds of approximately $2,000,000 (with an option to increase the size of the private placement by $1,000,000) (the "Private Placement"). The Company intends to close the...
2024-12-11 7:00 AM EST
MustGrow Biologics Signs Non-Binding Term-Sheet for Acquisition of NexusBioAg
Saskatoon, Saskatchewan--(Newsfile Corp. - November 27, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce the signing of a non-binding term-sheet (the "Term Sheet") dated November 27, 2024 with Univar Solutions Canada Ltd. ("Univar Solutions") for the proposed acquisition of certain assets that represent NexusBioAg ("NexusBioAg"). This strategic acquisition remains subject to certain conditions including completion of...
2024-11-27 6:43 PM EST
MustGrow Provides 2024 Pipeline Update
MustGrow transitions from R&D to commercialization. TerraSanteTM biofertility product manufacturing and sales has commenced, with potential initial sales ramp-up in 2025 and 2026. Commercialization of TerraMGTM soil biopesticide is progressing under the Bayer commercial agreement in the EU, Middle East and Africa. Registration work for TerraMGTM soil biopesticide continues in the U.S. and Canada. Expiration of exclusive non-commercial agreements. Intellectual property portfolio continues to...
2024-09-23 5:00 PM EDT
MustGrow Receiving Funding from Agriculture and Agri-Food Canada for Human and Animal Health Applications
Saskatoon, Saskatchewan--(Newsfile Corp. - September 17, 2024) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow") is pleased to announce funding from Agriculture and Agri-Food Canada ("AAFC") to investigate mustard-derived ingredient opportuni
2024-09-17 7:00 AM EDT